Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

Allogeneic hematopoietic stem cell transplantation (HCT) is the only curative treatment for myelodysplastic syndrome (MDS). The proportion of MDS patients referred for transplant evaluation, those undergoing transplantation and the reasons for not undergoing transplant are unknown. In this retrospec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biol Blood Marrow Transplant
Auteurs principaux: Getta, Bartlomiej M., Kishtagari, Ashwin, Hilden, Patrick, Tallman, Martin S., Maloy, Molly, Gonzales, Patrick, Castro-Malaspina, Hugo, Perales, Miguel-Angel, Giralt, Sergio, Tamari, Roni, Klimek, Virginia
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386429/
https://ncbi.nlm.nih.gov/pubmed/28336325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.03.020
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires